UCK1 IDG kinase ARCHS4 coexpression (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with UCK1 IDG kinase ARCHS4 coexpression.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with UCK1 IDG kinase ARCHS4 coexpression.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with UCK1 IDG kinase ARCHS4 coexpression.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with UCK1 IDG kinase ARCHS4 coexpression.

Results found

Linked to

 

Label

Description

 

Gene

GTP binding protein 6

Gene

nucleosome assembly protein 1 like 6, pseudogene

Gene

neurofibromin 1 pseudogene 8

Gene

mitogen-activated protein kinase kinase 4 pseudogene 1

Gene

kinesin light chain 2

Gene

solute carrier family 27 member 4

Gene

PRELI domain containing 1

Gene

transmembrane protein adipocyte associated 1

Gene

ribosomal protein L8

Gene

charged multivesicular body protein 1A

  • Gene

    GTP binding protein 6


  • Gene

    nucleosome assembly protein 1 like 6, pseudogene


  • Gene

    neurofibromin 1 pseudogene 8


  • Gene

    mitogen-activated protein kinase kinase 4 pseudogene 1


  • Gene

    kinesin light chain 2


  • Gene

    solute carrier family 27 member 4


  • Gene

    PRELI domain containing 1


  • Gene

    transmembrane protein adipocyte associated 1


  • Gene

    ribosomal protein L8


  • Gene

    charged multivesicular body protein 1A

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.